Literature DB >> 27678159

Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.

Janka Bábíčková1, Barbara M Klinkhammer2, Eva M Buhl3, Sonja Djudjaj2, Mareike Hoss4, Felix Heymann5, Frank Tacke5, Jürgen Floege6, Jan U Becker7, Peter Boor8.   

Abstract

Progressive renal diseases are associated with rarefaction of peritubular capillaries, but the ultrastructural and functional alterations of the microvasculature are not well described. To study this, we analyzed different time points during progressive kidney damage and fibrosis in 3 murine models of different disease etiologies. These models were unilateral ureteral obstruction, unilateral ischemia-reperfusion injury, and Col4a3-deficient mice, we analyzed ultrastructural alterations in patient biopsy specimens. Compared with kidneys of healthy mice, we found a significant and progressive reduction of peritubular capillaries in all models analyzed. Ultrastructurally, compared with the kidneys of control mice, focal widening of the subendothelial space and higher numbers of endothelial vacuoles and caveolae were found in fibrotic kidneys. Quantitative analysis showed that peritubular capillary endothelial cells in fibrotic kidneys had significantly and progressively reduced numbers of fenestrations and increased thickness of the cell soma and lamina densa of the capillary basement membrane. Similar ultrastructural changes were also observed in patient's kidney biopsy specimens. Compared with healthy murine kidneys, fibrotic kidneys had significantly increased extravasation of Evans blue dye in all 3 models. The extravasation could be visualized using 2-photon microscopy in real time in living animals and was mainly localized to capillary branching points. Finally, fibrotic kidneys in all models exhibited a significantly greater degree of interstitial deposition of fibrinogen. Thus, peritubular capillaries undergo significant ultrastructural and functional alterations during experimental progressive renal diseases, independent of the underlying injury. Analyses of these alterations could provide read-outs for the evaluation of therapeutic approaches targeting the renal microvasculature.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; endothelial cells; endothelial dysfunction; leakage; microvasculature; ultrastructure

Mesh:

Substances:

Year:  2016        PMID: 27678159     DOI: 10.1016/j.kint.2016.07.038

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

1.  Beraprost sodium mitigates renal interstitial fibrosis through repairing renal microvessels.

Authors:  Shulin Li; Yanping Wang; Lu Chen; Zhuojun Wang; Guodong Liu; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  J Mol Med (Berl)       Date:  2019-03-28       Impact factor: 4.599

2.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

3.  Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.

Authors:  Bing Yang; Shanshan Lan; Mélanie Dieudé; Jean-Paul Sabo-Vatasescu; Annie Karakeussian-Rimbaud; Julie Turgeon; Shijie Qi; Lakshman Gunaratnam; Natalie Patey; Marie-Josée Hébert
Journal:  J Am Soc Nephrol       Date:  2018-06-20       Impact factor: 10.121

Review 4.  The third path of tubulointerstitial fibrosis: aberrant endothelial secretome.

Authors:  Mark Lipphardt; Jong W Song; Kei Matsumoto; Sina Dadafarin; Hassan Dihazi; Gerhard Müller; Michael S Goligorsky
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

5.  Hepatocyte Growth Factor-Secreting Mesothelial Cell Sheets Suppress Progressive Fibrosis in a Rat Model of CKD.

Authors:  Masatoshi Oka; Sachiko Sekiya; Ryoichi Sakiyama; Tatsuya Shimizu; Kosaku Nitta
Journal:  J Am Soc Nephrol       Date:  2019-01-11       Impact factor: 10.121

Review 6.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

7.  Changes in cell fate determine the regenerative and functional capacity of the developing kidney before and after release of obstruction.

Authors:  Vidya K Nagalakshmi; Minghong Li; Soham Shah; Joseph C Gigliotti; Alexander L Klibanov; Frederick H Epstein; Robert L Chevalier; R Ariel Gomez; Maria Luisa S Sequeira-Lopez
Journal:  Clin Sci (Lond)       Date:  2018-12-05       Impact factor: 6.124

Review 8.  Targeting angiogenesis and lymphangiogenesis in kidney disease.

Authors:  Katsuyuki Tanabe; Jun Wada; Yasufumi Sato
Journal:  Nat Rev Nephrol       Date:  2020-03-06       Impact factor: 28.314

9.  Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated metabolic reprogramming in kidney fibrosis.

Authors:  Sara Lovisa; Eliot Fletcher-Sananikone; Hikaru Sugimoto; Janine Hensel; Sharmistha Lahiri; Alexandre Hertig; Gangadhar Taduri; Erica Lawson; Rajan Dewar; Ignacio Revuelta; Noritoshi Kato; Chang-Jiun Wu; Roland L Bassett; Nagireddy Putluri; Michael Zeisberg; Elisabeth M Zeisberg; Valerie S LeBleu; Raghu Kalluri
Journal:  Sci Signal       Date:  2020-06-09       Impact factor: 8.192

10.  Characterization of the PEGylated Functional Upstream Domain Peptide (PEG-FUD): a Potent Fibronectin Assembly Inhibitor with Potential as an Anti-Fibrotic Therapeutic.

Authors:  Pawel Zbyszynski; Bianca R Tomasini-Johansson; Donna M Peters; Glen S Kwon
Journal:  Pharm Res       Date:  2018-04-24       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.